Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

London close: US slide drags down Footsie

Thu, 28th Jan 2010 16:45

London slumped near the close mirroring heavy falls in the US where technology stocks ran into heavy selling seemingly on disappointment with Apple's new iPad.AstraZeneca led the fallers after the Anglo-Swedish pharmaceuticals firm saw fourth quarter earnings rise 10% but warned that its predicted 2010 revenues would be hit by the loss of exclusive rights to sell certain drugs.AstraZeneca also announced plans to chop 8,000 jobs from its 63,000 workforce.Pay TV and Internet service provider British Sky Broadcasting (BSkyB) had a strong second quarter with revenues coming in marginally ahead of expectations. Turnover in the six months to the end of December 2009 was £2.87bn, up 10% from £2.6bn the year before and better than the £2.86bn some brokers were tipping.Fellow broadcaster ITV raised eyebrows in the City by appointing Royal Mail boss Adam Crozier as its new chief executive. The appointment of Crozier, who had run the Football Association prior to joining Royal Mail, ends a long, and at times farcical, search for a replacement for Michael Grade, who announced last April he wanted to stand down.Banks fell back after an early bounce after the recent sell-off following President Obama's planned bank reforms. A number of senior figures slammed the proposals yesterday and noises out of Europe suggest they have not gone down well with governments here either. Barclays, Lloyds Banking and Royal Bank of Scotland closed down after early gains.It's been a busy day on the announcements front for miners. South African platinum miner Lonmin reiterated its sales and cost guidance for the year but said tonnes mined from its Marikana underground operations fell slightly in the first quarter.Kazakh industrial metals giant Kazakhmys saw copper cathode production fall by 7% in 2009 as it suspended four mines to cut costs amid a period of low prices for the red metal.After a strike ridden third quarter the final quarter of 2009 was much better for platinum producer Aquarius, with attributable production improving by around one-sixth. The group said platinum group metals dollar prices improved by 18% over the quarter.Sugar and sweetener manufacturer Tate & Lyle turned sour after saying its third quarter performance was marginally below expectations due to lower sales of industrial products in the Americas. Private equity group 3i said it has started 2010 in a strong financial position and has continued to see good realisations from its portfolio.Rolls-Royce has won a share of an order from Jetstar Airways for V2500 engines to power up to 90 Airbus A320 family aircraft. The order is worth up to $1.2bn to Rolls-Royce if all options are exercised.Deutsche Bank sees green shoots of recovery in Vodafone's second quarter performance but thinks these will be more apparent in the third quarter trading update and advises investors to buy the shares ahead of the recovery.The dark days appear to be behind specialist mortgage lender Paragon, with the company's portfolio of loans performing in line, but the group is not yet ready to start lending again. Redemptions in the final quarter of 2009 remained low and at similar levels to those seen in the six months to the end of September, while customer payment performance continues to be superior to market wide data, the company said.Arriva has admitted holding merger talks with France's state railway group SNCF after shares in the bus and train group jumped this morning. AG Barr said soft drinks sales over the final quarter came in better than company expectations and full year profit is now expected to come in ahead of market expectations.Support services group VT has continued to perform well since the end of September, with the order book remaining above £4bn.Stockbroker and fund manager Brewin Dolphin reported a 11.5% rise in first quarter income and said improved trading conditions have continued.Robert Wiseman Dairies said sales volume and turnover for the 17 week period ended 23 January are slightly ahead of management expectations. It's full steam ahead for energy efficiency company Eaga which claims its core markets are 'relatively insulated' from the depressed economic conditions.Consumer electronics group Armour expects to meet the current market expectations for the full year despite the disruption caused by the January weather.FTSE 100 - RisersCarnival (CCL) 2,272.00p +1.61%Next (NXT) 1,950.00p +1.30%RSA Insurance Group (RSA) 129.00p +0.94%Schroders NV (SDRC) 1,004.00p +0.90%FTSE 100 - FallersAstraZeneca (AZN) 2,905.00p -4.60%Xstrata (XTA) 1,004.50p -4.33%Antofagasta (ANTO) 885.50p -3.85%Man Group (EMG) 237.50p -3.46%FTSE 250 - RisersGreene King (GNK) 457.00p +3.25%National Express Group (NEX) 212.00p +3.16%Enterprise Inns (ETI) 117.40p +2.98%Arriva (ARI) 481.40p +2.89%FTSE 250 - FallersEcofin Water & Power Opportunities (ECWO) 133.10p -4.59%Tate & Lyle (TATE) 388.70p -4.52%Yell Group (YELL) 35.15p -3.99%Hochschild Mining (HOC) 265.40p -3.81%

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.